Effects of Ecopipam or Placebo in Adults With Stuttering (Speak Freely)
Status:
Recruiting
Trial end date:
2022-04-30
Target enrollment:
Participant gender:
Summary
This is a multicenter, randomized, double-blind, placebo-controlled, parallel-group, Phase 2
exploratory study in adult subjects with childhood onset fluency disorder.
Phase:
Phase 2
Details
Lead Sponsor:
Emalex Biosciences Inc.
Collaborators:
Premier Research Group plc University of California, Riverside